CIK 0001377121 · Large accelerated filer
Protagonist Therapeutics, Inc
Sign in to watch- Ticker
- PTGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980505495
- Phone
- (510) 474-0170
- Business address
- 7707 GATEWAY BLVD., SUITE 140, NEWARK, CA, 94560-1160
- Former names
- Protagonist Therapeutics Inc, Protagonist Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $26,552,861
- in 2 filings, $26.6M under 10b5-1 plans
Net −$26,552,861. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-26 | Gupta Suneel Chief Development Officer | Grant or award | +12,000 | 63,987 | ||
| 2021-02-26 | Gupta Suneel Chief Development Officer | Grant or award · Stock Option (right to buy) | +80,000 | 80,000 | ||
| 2021-02-11 | Noonberg Sarah B. Director | Grant or award | +3,700 | $6.98 | $26K | 3,700 |
| 2021-02-11 | Noonberg Sarah B. Director | Sale | −3,700 | $25.09 | $93K | 0 |
| 2021-02-11 | Noonberg Sarah B. Director | Option exercise · Stock Option (right to buy) | −3,700 | 3,600 | ||
| 2021-02-10 | Noonberg Sarah B. Director | Grant or award | +4,700 | $6.98 | $33K | 4,700 |
| 2021-02-10 | Noonberg Sarah B. Director | Sale | −4,300 | $25.42 | $109K | 400 |
| 2021-02-10 | Noonberg Sarah B. Director | Sale | −400 | $26.04 | $10K | 0 |
| 2021-02-10 | Noonberg Sarah B. Director | Option exercise · Stock Option (right to buy) | −4,700 | 7,300 | ||
| 2021-01-19 | PATEL DINESH V PH D President and CEO | Option exercise | +13,000 | $4.21 | $55K | 450,990 |
| 2021-01-19 | PATEL DINESH V PH D President and CEO | Sale | −24,846 | $24.60 | $611K | 426,144 |
| 2021-01-19 | PATEL DINESH V PH D President and CEO | Option exercise · Stock Option (right to buy) | −13,000 | 165,742 | ||
| 2020-08-17 | O'Dowd Sarah A Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2020-08-11 | KHOSLA CHAITAN PHD Director | Option exercise | +2,499 | $1.89 | $5K | 2,499 |
| 2020-08-11 | KHOSLA CHAITAN PHD Director | Sale | −2,499 | $17.19 | $43K | 0 |
| 2020-08-11 | KHOSLA CHAITAN PHD Director | Option exercise · Stock Option (right to buy) | −2,499 | 7,499 | ||
| 2020-05-28 | Williams Lewis T Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2020-05-28 | Waddill William D. Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2020-05-28 | SELICK HAROLD E Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2020-05-28 | Noonberg Sarah B. Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 |
Page 19 of 29 · 580 trades